In our study, we observed that treatment with BCP-DHA, regardless of the presence of infection, negatively regulated the gene expression of IL-2, IL-6, IRF7, NLRP3, and TYK2, acting directly in NF-ĸB inhibition and the synthesis and activity of pro-inflammatory cytokines (Fig. 7). The gene discussed is TYK2; the disease is infection.